Edwards Lifesciences Corporation (EW)
Largest Insider Buys in Sector
EW Stock Price History Chart
EW Stock Performance
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Insider Activity of Edwards Lifesciences Corporation
Over the last 12 months, insiders at Edwards Lifesciences Corporation have bought $49,753 and sold $60.09M worth of Edwards Lifesciences Corporation stock.
On average, over the past 5 years, insiders at Edwards Lifesciences Corporation have bought $109,049 and sold $93.15M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Zovighian Bernard J (CEO) — $49,753.
The last purchase of 580 shares for transaction amount of $49,753 was made by Zovighian Bernard J (CEO) on 2024‑05‑06.
List of Insider Buy and Sell Transactions, Edwards Lifesciences Corporation
| 2024-06-20 | Sale | Ullem Scott B. | CVP, Chief Financial Officer | 5,625 0.0009% | $87.51 | $492,258 | +2.32% | |
| 2024-06-20 | Sale | Lippis Daniel J. | CVP, JAPAC | 535 <0.0001% | $90.00 | $48,150 | +2.32% | |
| 2024-06-12 | Sale | BOBO DONALD E JR | CVP,Strategy/Corp Development | 5,000 0.0008% | $87.54 | $437,697 | +1.04% | |
| 2024-05-30 | Sale | Zovighian Bernard J | CEO | 8,617 0.0014% | $87.68 | $755,539 | -0.24% | |
| 2024-05-21 | Sale | Ullem Scott B. | CVP, Chief Financial Officer | 5,625 0.0009% | $90.45 | $508,803 | -2.99% | |
| 2024-05-10 | Sale | BOBO DONALD E JR | CVP,Strategy/Corp Development | 5,000 0.0008% | $87.81 | $439,038 | +1.30% | |
| 2024-05-07 | Sale | Lippis Daniel J. | CVP, JAPAC | 857 0.0001% | $85.60 | $73,359 | +2.12% | |
| 2024-05-06 | Zovighian Bernard J | CEO | 580.26 <0.0001% | $85.74 | $49,753 | +3.04% | ||
| 2024-05-02 | Sale | MUSSALLEM MICHAEL A | director | 29,350 0.0049% | $84.77 | $2.49M | +2.93% | |
| 2024-05-01 | Sale | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 14,400 0.0024% | $84.21 | $1.21M | +3.82% | |
| 2024-04-30 | Sale | Ullem Scott B. | CVP, Chief Financial Officer | 7,250 0.0012% | $85.80 | $622,062 | +3.31% | |
| 2024-04-09 | Sale | Lippis Daniel J. | CVP, JAPAC | 857 0.0001% | $92.34 | $79,135 | -6.00% | |
| 2024-04-08 | Sale | Lemercier Jean-Luc M | CVP, EMEACLA | 14,400 0.0024% | $92.32 | $1.33M | -5.17% | |
| 2024-04-08 | Sale | BOBO DONALD E JR | CVP,Strategy/Corp Development | 12,500 0.0021% | $92.33 | $1.15M | -5.17% | |
| 2024-04-04 | Sale | MUSSALLEM MICHAEL A | director | 29,350 0.0049% | $92.42 | $2.71M | -3.87% | |
| 2024-04-01 | Sale | Ullem Scott B. | CVP, Chief Financial Officer | 7,255 0.0012% | $94.89 | $688,423 | -6.92% | |
| 2024-03-13 | Sale | BOBO DONALD E JR | CVP,Strategy/Corp Development | 14,500 0.0024% | $91.01 | $1.32M | -5.15% | |
| 2024-03-11 | Sale | Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 14,400 0.0024% | $91.68 | $1.32M | -2.54% | |
| 2024-03-07 | Sale | Lippis Daniel J. | CVP, JAPAC | 1,715 0.0003% | $90.98 | $156,031 | -5.54% | |
| 2024-03-04 | Sale | MUSSALLEM MICHAEL A | director | 29,350 0.0049% | $86.67 | $2.54M | +1.78% |
Insider Historical Profitability
| Wood Larry L | Global President TAVR & Surg | 213794 0.0353% | $91.56 | 0 | 99 | |
| Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 173849 0.0284% | $91.56 | 0 | 24 | |
| BOBO DONALD E JR | CVP,Strategy/Corp Development | 46936 0.0065% | $91.56 | 0 | 139 | |
| Szyman Catherine M. | CVP, Critical Care | 34814 0.0057% | $91.56 | 1 | 56 | +31.99% |
| STONE HEISZ LESLIE | director | 26980 0.0044% | $91.56 | 0 | 4 | |
| Chopra Daveen | CVP, TMTT | 22750 0.0039% | $91.56 | 0 | 15 | |
| Zovighian Bernard J | CVP, TMTT | 68218 0.0035% | $91.56 | 1 | 6 | |
| Ullem Scott B. | CVP, Chief Financial Officer | 30561 0.0032% | $91.56 | 0 | 34 | |
| Lippis Daniel J. | CVP, JAPAC | 23513 0.0029% | $91.56 | 0 | 4 | |
| SELLERS ROBERT W.A. | SVP, Corporate Controller | 13087 0.0022% | $91.56 | 0 | 18 | |
| MUSSALLEM MICHAEL A | director | 4486 0.0007% | $91.56 | 0 | 239 | |
| GALLAHUE KIERAN | director | 67219 0.0006% | $91.56 | 2 | 2 | +27.32% |
| Verguet Patrick B | CVP, Europe | 129137 0.0213% | $91.56 | 0 | 91 | |
| KEHL JOHN H JR | CVP, Strategy & Corp Dev | 102839 0.017% | $91.56 | 0 | 27 | |
| WANG HUIMIN | CVP, Japan & Intercontinental | 99381 0.0164% | $91.56 | 0 | 156 | |
| Cardis John T | director | 91458 0.0151% | $91.56 | 0 | 5 | |
| BOWLIN MICHAEL R | director | 81751 0.0135% | $91.56 | 0 | 10 | |
| VALERIANI NICHOLAS J | director | 63811 0.0105% | $91.56 | 1 | 1 | <0.0001% |
| GARREN BRUCE P | CVP, Public Affairs/Special Co | 62748 0.0103% | $91.56 | 0 | 17 | |
| PYOTT DAVID E I | director | 48429 0.008% | $91.56 | 1 | 6 | +10.01% |
| MCNEIL BARBARA J | director | 46454 0.0077% | $91.56 | 1 | 5 | +33.89% |
| Abate Thomas M | CVP, CFO | 44393 0.0073% | $91.56 | 0 | 23 | |
| Solomon Carlyn D | CVP, Critical Care & Vascular | 31154 0.0051% | $91.56 | 0 | 18 | |
| INGRAM ROBERT ALEXANDER | director | 30541 0.005% | $91.56 | 0 | 5 | |
| BESSLER ANITA | CVP | 29410 0.0048% | $91.56 | 0 | 7 | |
| NEAL PHILIP M | director | 27333 0.0045% | $91.56 | 0 | 1 | |
| Marsh Martha H. | 26777 0.0044% | $91.56 | 0 | 1 | ||
| FOSTER STUART L | CVP, Critical Care / Vascular | 17300 0.0029% | $91.56 | 0 | 8 | |
| Nevinny Corinne H | CVP & Pres., Global Ops | 16687 0.0028% | $91.56 | 0 | 13 | |
| LOUCKS VERNON R JR | director | 17106 0.0028% | $91.56 | 0 | 2 | |
| Redmond Paul C | CVP, Global Operations | 12534 0.0021% | $91.56 | 0 | 14 | |
| Martin John Alexander | CVP, North America | 11300 0.0019% | $91.56 | 0 | 1 | |
| VON SCHACK WESLEY W | director | 8000 0.0013% | $91.56 | 3 | 6 | +20.17% |
| LORANGER STEVEN R | director | 5000 0.0008% | $91.56 | 1 | 0 | <0.0001% |
| LINK WILLIAM J PHD | director | 4722 0.0008% | $91.56 | 0 | 5 | |
| McCauley Christine Z | CVP, Human Resources | 4234 0.0007% | $91.56 | 0 | 1 | |
| WOODGRIFT RANDEL WILLIAM | Corp VP, Manufacturing Ops | 3349 0.0006% | $91.56 | 0 | 4 | |
| REINDL ROBERT C | CVP, H.R. and Communications | 1124 0.0002% | $91.56 | 0 | 23 |
Institutional Investor Ownership
| The Vanguard Group | $5.06B | 8.79 | 52.96M | +1.15% | +$57.43M | 0.1 | |
| BlackRock | $5.01B | 8.7 | 52.42M | +0.47% | +$23.59M | 0.11 | |
| State Street | $2.56B | 4.44 | 26.78M | -0.67% | -$17.19M | 0.11 | |
| BNY Mellon | $1.81B | 3.15 | 18.97M | +9.49% | +$157.18M | 0.34 | |
| Brown Advisory | $1.59B | 2.76 | 16.64M | -8.5% | -$147.67M | 2.13 | |
| AllianceBernstein | $1.57B | 2.72 | 16.41M | -14.05% | -$256.38M | 0.56 | |
| Wellington Management Company | $1.49B | 2.58 | 15.55M | -7.59% | -$122.1M | 0.25 | |
| Geode Capital Management | $1.25B | 2.17 | 13.09M | +1.76% | +$21.58M | 0.11 | |
| JPMorgan Chase | $914.88M | 1.59 | 9.57M | +23.01% | +$171.13M | 0.08 | |
| Fidelity Investments | $787.37M | 1.37 | 8.24M | +9.83% | +$70.47M | 0.05 | |
| Fisher Asset Management Llc | $728.82M | 1.27 | 7.63M | +7% | +$47.65M | 0.34 | |
| T. Rowe Price | $622.7M | 1.08 | 6.52M | +57.93% | +$228.4M | 0.08 | |
| Morgan Stanley | $590.47M | 1.03 | 6.18M | +1.16% | +$6.78M | 0.05 | |
| Sands Capital | $554.49M | 0.96 | 5.8M | -4.93% | -$28.78M | 1.55 | |
| Northern Trust | $550.94M | 0.96 | 5.77M | -3.14% | -$17.86M | 0.09 | |
| Invesco | $542.62M | 0.94 | 5.68M | +37.88% | +$149.08M | 0.11 | |
| Amundi | $480.1M | 0.92 | 5.52M | -11.41% | -$61.81M | 0.2 | |
| Legal & General | $512.62M | 0.89 | 5.36M | -2.31% | -$12.11M | 0.12 | |
| Janus Henderson | $504.25M | 0.88 | 5.28M | -5.27% | -$28.07M | 0.28 | |
| Winslow Capital Management Llc | $483.41M | 0.84 | 5.06M | New | +$483.41M | 1.82 | |
| Ubs Asset Management Americas Inc | $420.41M | 0.73 | 4.4M | +10.19% | +$38.89M | 0.15 | |
| Wellcome Trust Ltd The As Trustee Of The Wellcome Trust | $391.8M | 0.68 | 4.1M | 0% | +$0 | 4.71 | |
| Deutsche Bank | $347.13M | 0.6 | 3.63M | -6% | -$22.18M | 0.16 | |
| Charles Schwab | $341.59M | 0.59 | 3.57M | +3.65% | +$12.01M | 0.08 | |
| Goldman Sachs | $334.48M | 0.58 | 3.5M | -0.37% | -$1.24M | 0.06 | |
| Holocene Advisors, LP | $324.78M | 0.56 | 3.4M | +285.8% | +$240.59M | 1.2 | |
| Voya Investment Management LLC | $318.39M | 0.55 | 3.33M | +1,088.37% | +$291.6M | 0.36 | |
| Ownership Capital | $308.65M | 0.54 | 3.23M | -7.45% | -$24.84M | 7.06 | |
| Point72 Asset Management | $283.89M | 0.49 | 2.97M | New | +$283.89M | 0.54 | |
| Champlain Investment Partners, LLC | $283.26M | 0.49 | 2.96M | +3.07% | +$8.43M | 1.63 | |
| Cibc Private Wealth Group Llc | $267M | 0.47 | 2.83M | -17.81% | -$57.86M | 0.54 | |
| Royal Bank of Canada | $260.7M | 0.45 | 2.73M | +2.48% | +$6.31M | 0.06 | |
| Citadel Advisors LLC | $252.79M | 0.44 | 2.65M | +764.76% | +$223.56M | 0.16 | |
| Nuveen | $246.47M | 0.43 | 2.58M | -11.2% | -$31.08M | 0.07 | |
| Ameriprise Financial | $235.77M | 0.41 | 2.45M | +34.81% | +$60.87M | 0.07 | |
| AustralianSuper | $229.44M | 0.4 | 2.43M | +10.15% | +$21.14M | 1.34 | |
| Capital International Investors | $211.85M | 0.37 | 2.22M | -75.48% | -$652.16M | 0.04 | |
| Nordea Investment Management Ab | $202.93M | 0.36 | 2.14M | +32.7% | +$50M | 0.24 | |
| The Manufacturers Life Insurance Company | $196.48M | 0.34 | 2.06M | +162.67% | +$121.68M | 0.18 | |
| American Century Investments | $194.92M | 0.34 | 2.04M | -3.62% | -$7.32M | 0.12 | |
| DekaBank | $188.38M | 0.33 | 1.96M | -13.85% | -$30.29M | 0.35 | |
| Bank of America | $182.07M | 0.32 | 1.91M | -32.67% | -$88.33M | 0.02 | |
| PRIMECAP Management Co | $181.66M | 0.32 | 1.9M | 0% | +$0 | 0.14 | |
| Macquarie Group | $178.35M | 0.31 | 1.87M | -6.7% | -$12.8M | 0.15 | |
| Swiss National Bank | $173.57M | 0.3 | 1.82M | -4.46% | -$8.09M | 0.12 | |
| Raymond James Associates | $169.63M | 0.3 | 1.78M | +8.53% | +$13.33M | 0.12 | |
| HSBC | $169.67M | 0.3 | 1.78M | +9.85% | +$15.21M | 0.12 | |
| Credit Suisse | $154.37M | 0.27 | 1.62M | +1.98% | +$2.99M | 0.14 | |
| Sumitomo Mitsui Trust Holdings | $153.84M | 0.27 | 1.61M | +0.41% | +$627,160.28 | 0.11 | |
| Handelsbanken | $150.78M | 0.26 | 1.58M | -2.01% | -$3.09M | 0.65 |